Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
Number of shares outstanding for Jiangsu Hengrui Medicine
(600276.SS)
Number of shares outstanding as of April 2024 : 6,521,618,391
According to Jiangsu Hengrui Medicine
's latest financial reports and stock price the company's current number of shares outstanding is 6,521,618,391.
At the end of 2023 the company had 6,521,618,391 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Jiangsu Hengrui Medicine
from 2022 to 2023